A detailed history of Susquehanna International Group, LLP transactions in Abb Vie Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 325,187 shares of ABBV stock, worth $53.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
325,187
Previous 452,895 28.2%
Holding current value
$53.7 Million
Previous $77.7 Million 17.33%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $20.9 Million - $25.5 Million
-127,708 Reduced 28.2%
325,187 $64.2 Million
Q2 2024

Aug 15, 2024

SELL
$154.79 - $180.76 $16.5 Million - $19.3 Million
-106,898 Reduced 19.1%
452,895 $77.7 Million
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $58.4 Million - $66.6 Million
-365,713 Reduced 39.51%
559,793 $102 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $18.1 Million - $20.4 Million
131,656 Added 16.58%
925,506 $143 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $10.6 Million - $12.3 Million
-79,524 Reduced 9.11%
793,850 $118 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $53.6 Million - $66.7 Million
-404,255 Reduced 31.64%
873,374 $118 Million
Q1 2023

May 16, 2023

BUY
$144.61 - $166.54 $77.2 Million - $88.9 Million
534,056 Added 71.82%
1,277,629 $204 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $79 Million - $94.7 Million
571,001 Added 330.88%
743,573 $120 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $19 Million - $21.8 Million
-141,362 Reduced 45.03%
172,572 $23.2 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $18.5 Million - $23.5 Million
-134,223 Reduced 29.95%
313,934 $48.1 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $281 Million - $349 Million
-2,128,255 Reduced 82.61%
448,157 $72.7 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $101 Million - $127 Million
936,111 Added 57.07%
2,576,412 $349 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $39.4 Million - $44.7 Million
370,430 Added 29.17%
1,640,301 $177 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $19.1 Million - $21.3 Million
181,900 Added 16.72%
1,269,871 $143 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $25.4 Million - $28 Million
248,432 Added 29.59%
1,087,971 $118 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $123 Million - $166 Million
-1,523,027 Reduced 64.46%
839,539 $90 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $60.3 Million - $70.8 Million
701,718 Added 42.25%
2,362,566 $207 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $20.8 Million - $27.9 Million
-283,686 Reduced 14.59%
1,660,848 $163 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $2.49 Million - $3.77 Million
-38,566 Reduced 1.94%
1,944,534 $148 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $15.5 Million - $19.4 Million
215,476 Added 12.19%
1,983,100 $176 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $38.5 Million - $46.3 Million
-611,709 Reduced 25.71%
1,767,624 $134 Million
Q2 2019

Aug 16, 2019

BUY
$65.7 - $83.98 $11.5 Million - $14.6 Million
174,294 Added 7.9%
2,379,333 $173 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $114 Million - $145 Million
1,729,849 Added 364.03%
2,205,039 $160 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $26.4 Million - $31.1 Million
342,556 Added 258.27%
475,190 $38.3 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $16.5 Million - $18.3 Million
-185,545 Reduced 58.31%
132,634 $12.5 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $14.1 Million - $16.6 Million
156,683 Added 97.02%
318,179 $29.5 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $10.7 Million - $14.3 Million
115,896 Added 254.16%
161,496 $15.3 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $15.8 Million - $17.4 Million
-176,896 Reduced 79.51%
45,600 $4.41 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $15.5 Million - $19.9 Million
222,496
222,496 $19.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.